Trial Site Detail

 

Drug:
Imatinib + Selinexor
Trial:
Selinexor in Combination With Imatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors. (SeliGIST)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Active, not recruiting

 

Hospital Virgen del Rocio

     
Sevilla , 41013
Spain

 

Principal Investigator:
 Javier Martín Broto, MD
Contact:
 Laura Bernal, SC 671 533 319 laura.bernal.exts@juntadeandalucia.es
Activation Status of this Site:
 Closed
Notes about this Site:
Hospital Virgen del Rocio Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.